Effects of Neoadjuvant Chemotherapy on Multiple Cytokines in Patients with Tri-negative Breast Cancer
Abstract
Keywords
Full Text:
PDFReferences
Han RB, Ren Y. Effects of neoadjuvant chemotherapy on sex hormones and serum cytokines in postmenopausal breast cancer patients [J]. Chinese Journal of Clinical Oncology and Rehabilitation, 2008, 25(4) : 45-48.
Liu XB, Huang GX. Changes of cytokines and serum tumor markers in elderly breast cancer patients [J]. Journal of Hainan Medical University, 2012, 212(13) : 71-73.
Luo FM Tang BL, Zou XL. Effect of autologous DC-CIK cell therapy on postoperative immune function of patients with triple negative breast cancer [J]. Chinese Journal of Oncology Clinical And Rehabilitation, 2017, 24(8) : 967-970.
Sun P. Effect of breast conserving surgery on serum markers, NK cells, CD19~+ cells and postoperative recurrence in breast cancer patients [J]. Journal of Practical Clinical Medicine, 2012, 22(15) : 59-62.
Guo ZH, Hu QL, Zhou Q, et al. Changes and clinical significance of serum tumor markers, cytokines and sialic acid levels in patients with breast disease [J]. Advances in modern biomedicine, 2017,17 (33) : 6549-6552.
Li XG, Liu JX. Effect of cancer combined with neoadjuvant chemotherapy on the expression of proliferative molecules and immune function in breast cancer patients [J]. Journal of hai nan medical college, 2017,23 (22) : 3096-3099.
Chen LJ. Clinical efficacy of bevacizumab combined with TP regimen in the treatment of advanced HER2-negative breast cancer and its influence on the level of related cytokines in patients [J]. Marker immunoanalysis and Clinical Practice, 2012, 141(7) : 49-51, 72.
Zheng TZ, Pang ZY, Zhang Q. Short-term efficacy of docetaxel combined with epirubicin in the treatment of locally advanced breast cancer and its effect on serum tumor markers [J]. Cancer Progression, 2016, 16(15) : 70-73.
DOI: http://dx.doi.org/10.30564/amor.v5i3.243
Refbacks
- There are currently no refbacks.
Copyright (c) 2020 Adam R Botha

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.